Journals / European Journal of Rheumatology / 2016 / Cilt: 3 - Sayı: 1

Vaccination recommendations for adult patients with rheumatic diseases

Pages
29–35
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review will consider the immunization process followed in rheumatic diseases and also refer to its application.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Infectious diseases in any age group can be successfully prevented through immunization.
📊
Key Findings & Data:Protection provided through immunization in childhood decreases over the years.
💡
Conclusion & Impact:This review will consider the immunization process followed in rheumatic diseases and also refer to its application.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Infectious diseases in any age group can be successfully prevented through immunization. Protection provided through immunization in childhood decreases over the years. Immunization in adulthood is important because of the growing elderly population, chronic diseases, and globalization. Recommendations on this subject are being constantly updated through scientific guidelines. Immunization in adulthood is also important in rheumatology. There is an increased risk not only of infection in rheumatic diseases but also of infections being more severe. Most infections, and their frequently observed complications, are among those diseases that can be prevented through immunization. The type of immunization, immunosuppressive/immunomodulatory therapy received by the patient, disease activity, and presence of chronic diseases affect the immunization process in patients with rheumatic diseases. This review will consider the immunization process followed in rheumatic diseases and also refer to its application.

🔖

Cite This Article

KARADAĞ, Ö., AKAR², S., KİRAZ, S., ERTENLİ, İ., TÜRKÇAPAR, N., TANRIÖVER, M. D. (2022). Vaccination recommendations for adult patients with rheumatic diseases. European Journal of Rheumatology, Cilt: 3 - Sayı: 1, 29–35. https://ajindex.com/articles/650459

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Lang PO, Govind S, Michel JP, Aspinall R, Mitch- ell WA. Immunosenescence: Implications for vaccination programmes in adults. Maturitas 2011; 68: 322-30. [CrossRef] European Commission, Aging Report. Available from: http://ec.europa.eu/economy_finance/ publications/european_economy/ageing_re- port/index_en.htm VPD Surveillance Manual, 5th ed, 2011. National Sur- veillance of Vaccine-Preventable Diseases: Chapter 23-1. Available from: http://www.cdc.gov/vaccines/ pubs/surv-manual/chpt23-natl-surv-vpd.pdf Health Protection Report: Weekly report. Available from: http://www.hpa.org.uk/hpr/ar- chives/2012/news1512.htm Williams WW, Lu PJ, O'Halloran A, Bridges CB, Pil- ishvili T, Hales CM, et al. Noninfluenza vaccination coverage among adults--United States, 2012. MMWR Morb Mortal Wkly Rep 2014; 63: 95-102.
  2. Carrillo-Santisteve P, Lopalco PL. Measles still spreads in Europe: who is responsible for the failure to vaccinate? Clin Microbiol Infect 2012; 18(Suppl 5): 50-6. [CrossRef] Ortac Ersoy E, Tanriover MD, Ocal S, Ozisik L, Inkaya C, Topeli A. Severe measles pneumonia in adults with respiratory failure: role of ribavi- rin and high-dose vitamin A. Clin Respir J 2015. Advisory Committee on Immunization Practic- es. Recommended Adult Immunization Sched- ule: United States, 2015. Ann Intern Med 2015; 162: 214-23. Erişkin Bağışıklama Kılavuzu. Available from: http://ekmud.org.tr/e-akademi/rehberler/
  3. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with con- trols: a population-based study. Arthritis Rheum 2002; 46: 2287-93. [CrossRef] Blumentals WA, Arreglado A, Napalkov P, Toov- ey S. Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study. BMC Musculoskel- et Disord 2012; 13: 158. [CrossRef] Kobashigawa T, Nakajima A, Taniguchi A, In- oue E, Tanaka E, Momohara S, et al. Vaccination against seasonal influenza is effective in Jap- anese patients with rheumatoid arthritis en- rolled in a large observational cohort. Scand J Rheumatol 2013; 42: 445-50. [CrossRef] van Assen S, Elkayam O, Agmon-Levin N, Cerve- ra R, Doran MF, Dougados M, et al. Vaccination in adult patients with auto-immune inflamma- tory rheumatic diseases: a systematic literature review for the European League Against Rheu- matism evidence-based recommendations for vaccination in adult patients with auto-im- mune inflammatory rheumatic diseases. Auto- immun Rev 201